Boston Scientific Corp. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
121
119
239
347
104
1,671
Depreciation, Depletion & Amortization
689
725
769
815
844
894
Other Funds
160
85
222
127
98
95
Funds from Operations
927
307
320
976
1,360
2,470
Changes in Working Capital
155
962
280
4
66
2,160
Net Operating Cash Flow
1,082
1,269
600
972
1,426
310
Capital Expenditures
245
259
247
376
319
Sale of Fixed Assets & Businesses
83
12
-
29
-
Purchase/Sale of Investments
39
12
205
132
131
Net Investing Cash Flow
475
745
2,186
887
1,010
Issuance/Reduction of Debt, Net
10
-
1,430
190
123
Net Financing Cash Flow
596
150
1,322
206
110
Net Change in Cash
10
370
268
123
530
Free Cash Flow
837
1,010
353
596
1,107
Deferred Taxes & Investment Tax Credit
223
397
-
-
-
-
Net Assets from Acquisitions
274
486
1,734
408
560
Change in Capital Stock
426
65
114
111
85
Exchange Rate Effect
1
4
4
2
4
About Boston Scientific
View Profile
